Ignite Creation Date:
2025-12-25 @ 3:32 AM
Ignite Modification Date:
2026-01-09 @ 9:54 PM
Study NCT ID:
NCT04040205
Status:
RECRUITING
Last Update Posted:
2025-07-20
First Post:
2019-07-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
Sponsor:
Medical College of Wisconsin
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-07
Start Date Type:
ACTUAL
Primary Completion Date:
2027-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2019-07-29
First Submit QC Date:
None
Study First Post Date:
2019-07-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-16
Last Update Post Date:
2025-07-20
Last Update Post Date Type:
ACTUAL